Intellectus Partners Portfolio holdings
Top Buys
| 1 |
Twist Bioscience
TWST
|
+$6.45M |
| 2 |
Gilead Sciences
GILD
|
+$4.06M |
| 3 |
FIT
Fitbit, Inc. Class A common stock
FIT
|
+$3.01M |
| 4 |
Qualcomm
QCOM
|
+$835K |
| 5 |
Accenture
ACN
|
+$787K |
Top Sells
| 1 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$4.44M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$3.6M |
| 3 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$3.01M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.85M |
| 5 |
DSL
DoubleLine Income Solutions Fund
DSL
|
+$2.59M |
Sector Composition
| 1 | Communication Services | 21.43% |
| 2 | Technology | 17.05% |
| 3 | Healthcare | 16.09% |
| 4 | Consumer Discretionary | 16.06% |
| 5 | Financials | 10.03% |
Similar funds
Intellectus Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Intellectus Partners held 607 positions worth $146M, down 49% from $286M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Intellectus Partners withdrew a net $112M in Q4 2018, closing 333 positions and reducing 120 holdings. Its most notable exit was WisdomTree Japan Hedged Equity Fund, an estimated $4.44M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 21% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Intellectus Partners opened a new position in Twist Bioscience worth $4.08M.
- Intellectus Partners's largest Q4 2018 buy was Twist Bioscience: 291,112 shares worth $4.08M.
- Intellectus Partners added most to Gilead Sciences in Q4 2018, an estimated $4.06M increase.
- Intellectus Partners's biggest Q4 2018 reduction was IBM, cutting an estimated $2.51M.
- Intellectus Partners fully exited WisdomTree Japan Hedged Equity Fund in Q4 2018, selling an estimated $4.44M.
- Intellectus Partners's ten largest holdings make up 38% of its $146M portfolio in Q4 2018.
- Intellectus Partners opened 26 new positions and closed 333 in Q4 2018.
- Intellectus Partners's portfolio value fell 49% quarter-over-quarter to $146M.
Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.